2005
DOI: 10.1186/1471-2164-6-138
|View full text |Cite
|
Sign up to set email alerts
|

Identification of disease causing loci using an array-based genotyping approach on pooled DNA

Abstract: Background: Pooling genomic DNA samples within clinical classes of disease followed by genotyping on whole-genome SNP microarrays, allows for rapid and inexpensive genome-wide association studies. Key to the success of these studies is the accuracy of the allelic frequency calculations, the ability to identify false-positives arising from assay variability and the ability to better resolve association signals through analysis of neighbouring SNPs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
57
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(64 citation statements)
references
References 20 publications
2
57
0
Order By: Relevance
“…Most pooling-based GWA studies use, like us in the current study, a two-stage design in which the most promising SNPs identified in the screening stage are followed up by individual genotyping. The effectiveness of this method has been successfully demonstrated by the identification of previously published as well as novel susceptibility loci [8,9,10,11,12]. …”
Section: Discussionmentioning
confidence: 89%
See 1 more Smart Citation
“…Most pooling-based GWA studies use, like us in the current study, a two-stage design in which the most promising SNPs identified in the screening stage are followed up by individual genotyping. The effectiveness of this method has been successfully demonstrated by the identification of previously published as well as novel susceptibility loci [8,9,10,11,12]. …”
Section: Discussionmentioning
confidence: 89%
“…They are an excellent but, unfortunately, expensive approach to identify genes and pathways involved in complex diseases. Pooling DNA in the first stage of a GWA study substantially reduces costs, and has been shown to be an efficient method to select candidate susceptibility loci for follow-up by individual genotyping [7,8,9,10,11,12,13]. To identify novel pancreatic cancer susceptibility loci, we conducted a two-stage GWA study using the Affymetrix® Genome-Wide Human SNP Array 6.0 (>900,000 single-nucleotide polymorphisms, SNPs) and DNA pooling in the screening stage.…”
Section: Introductionmentioning
confidence: 99%
“… a Correction methods used include those based on (1) Hoogendoorn et al [6], (2) Meaburn et al [7], (3) Craig et al [8] plus Meaburn et al [7], and (4) no adjustment. b Mean of the absolute values for the differences in allele frequencies between DNA pools and individual samples. c In total, 108 SNPs were compared for allele frequency differences as estimated for DNA pools and individual DNA samples. However, only 105 SNPs were compared for the correction method (3) (Craig et al [8] plus Meaburn et al [7]) because 3 SNPs were filtered out.…”
Section: Resultsmentioning
confidence: 99%
“…However, only 105 SNPs were compared for the correction method (3) (Craig et al [8] plus Meaburn et al [7]) because 3 SNPs were filtered out.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, if RAS values generated using pooled DNA samples from one group (e. g. patients) shall be compared to averaged SNP-specific call values generated by individual genotyping of a different group (e. g. healthy control individuals), a correction step has to be included to compensate for this hybridization-specific bias [19]. One option is provided by the so called k-correction [8,12,14,20], which corrects the RAS value for heterozygote calls. The correction factor c is specific for each probe set and has to be determined empirically by individual array-based genotyping of heterozygous individuals.…”
Section: Methodsmentioning
confidence: 99%